Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

508 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
de Gruijl TD, Bontkes HJ, Walboomers JM, Schiller JT, Stukart MJ, Groot BS, Chabaud MM, Remmink AJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ. de Gruijl TD, et al. Among authors: scheper rj. J Natl Cancer Inst. 1997 May 7;89(9):630-8. doi: 10.1093/jnci/89.9.630. J Natl Cancer Inst. 1997. PMID: 9150187
CD4(+)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia.
Molling JW, de Gruijl TD, Glim J, Moreno M, Rozendaal L, Meijer CJ, van den Eertwegh AJ, Scheper RJ, von Blomberg ME, Bontkes HJ. Molling JW, et al. Among authors: scheper rj. Int J Cancer. 2007 Oct 15;121(8):1749-55. doi: 10.1002/ijc.22894. Int J Cancer. 2007. PMID: 17582606
Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
de Gruijl TD, Bontkes HJ, Walboomers JM, Coursaget P, Stukart MJ, Dupuy C, Kueter E, Verheijen RH, Helmerhorst TJ, Duggan-Keen MF, Stern PL, Meijer CJ, Scheper RJ. de Gruijl TD, et al. Among authors: scheper rj. J Gen Virol. 1999 Feb;80 ( Pt 2):399-408. doi: 10.1099/0022-1317-80-2-399. J Gen Virol. 1999. PMID: 10073700
Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.
Bontkes HJ, de Gruijl TD, Walboomers JM, Schiller JT, Dillner J, Helmerhorst TJ, Verheijen RH, Scheper RJ, Meijer CJ. Bontkes HJ, et al. Among authors: scheper rj. J Gen Virol. 1999 Feb;80 ( Pt 2):409-417. doi: 10.1099/0022-1317-80-2-409. J Gen Virol. 1999. PMID: 10073701
T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection.
de Gruijl TD, Bontkes HJ, Stukart MJ, Walboomers JM, Remmink AJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ. de Gruijl TD, et al. Among authors: scheper rj. J Gen Virol. 1996 Sep;77 ( Pt 9):2183-91. doi: 10.1099/0022-1317-77-9-2183. J Gen Virol. 1996. PMID: 8811018
Analysis of IgG reactivity against Human Papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: results of a prospective study.
de Gruijl TD, Bontkes HJ, Walboomers JM, Stukart MJ, Robbesom AA, von Blomberg-van der Flier BM, Herbrink P, Remmink AJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ. de Gruijl TD, et al. Among authors: scheper rj. Int J Cancer. 1996 Dec 11;68(6):731-8. doi: 10.1002/(SICI)1097-0215(19961211)68:6<731::AID-IJC7>3.0.CO;2-4. Int J Cancer. 1996. PMID: 8980175
508 results